Quest Diagnostics

DGX59

S&P500

$163.59arrow_drop_down0.22%-$0.37

S&P500

DGX59

$163.59

arrow_drop_down0.22%-$0.37

S&P500

Performance History

Key Stats
Open	$164.00
Prev. Close	$163.89
EPS	7.44

Next Earnings Date	Jan 21, 2025

	LOW	HIGH
Day Range	161.51	165.17
52 Week Range	120.10	165.17

Ratios







EPS	7.44

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Quest Diagnostics (DGX)

Quest Diagnostics Inc (DGX) is a leading provider of diagnostic testing, information, and services. With a market cap of over $14 billion, the company operates a network of laboratories and service centers throughout the United States. Quest Diagnostics offers a wide range of diagnostic testing services, including routine and specialty testing, such as molecular and genetic testing, as well as advanced diagnostic information technology solutions.

The stock price history of Quest Diagnostics Inc (DGX) has shown steady growth over the years. The company has consistently delivered strong financial performance, with increasing revenues and earnings. The stock has been a reliable performer, providing investors with consistent returns. The PEG ratio, which measures the stock's valuation relative to its growth prospects, is favorable for DGX, indicating that it may be undervalued compared to its earnings growth potential.

Websitecall_made

Sector: Healthcare
Industry: Diagnostics & Research
CEO: Mr. James E. Davis
Headquarters: Secaucus
Employees: 40000
Exchange: NYSE

Keep an eye on Quest Diagnostics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Quest Diagnostics 's (DGX) price per share?

The current price per share for Quest Diagnostics (DGX) is $163.59. The stock has seen a price change of -$0.38 recently, indicating a -0.23% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Quest Diagnostics (DGX)?

For Quest Diagnostics (DGX), the 52-week high is $165.18, which is 0.97% from the current price. The 52-week low is $120.1, the current price is 36.21% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Quest Diagnostics (DGX) a growth stock?

Quest Diagnostics (DGX) has shown an average price growth of -4.13% over the past three years. It has received a score of 53 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Quest Diagnostics as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Quest Diagnostics (DGX) stock price performance year to date (YTD)?

As of the latest data, Quest Diagnostics (DGX) has a year-to-date price change of 16.17%. Over the past month, the stock has experienced a price change of 3.89%. Over the last three months, the change has been 7.03%. Over the past six months, the figure is 15.32%. Looking at a longer horizon, the five-year price change stands at 54.46%.

help

Is Quest Diagnostics (DGX) a profitable company?

Quest Diagnostics (DGX) has a net income of $850M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 33% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 14.19% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $9.25B, although specific revenue growth data is currently not available. The gross profit is $3.05B. Operating income is noted at $1.26B. Furthermore, the EBITDA is $1.78B.

help

What is the market capitalization of Quest Diagnostics (DGX)?

Quest Diagnostics (DGX) has a market capitalization of $18.26B. The average daily trading volume is 164.06, indicating the stock's liquidity and investor engagement.